Metabolic benefits of novel histamine H3 receptor ligands in the model of excessive eating: The importance of intrinsic activity and pharmacokinetic properties
Aims: One of the therapeutic approaches in the treatment of obesity is the use of histamine H3 receptor ligands. Histamine plays a significant role in eating behavior because it causes a loss of appetite and is considered to be a satiety signal released during food intake. Material and methods: Hist...
Main Authors: | Kamil Mika, Małgorzata Szafarz, Marek Bednarski, Kamil Kuder, Katarzyna Szczepańska, Krzysztof Pociecha, Bartosz Pomierny, Katarzyna Kieć-Kononowicz, Jacek Sapa, Magdalena Kotańska |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2021-10-01
|
Series: | Biomedicine & Pharmacotherapy |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S0753332221007344 |
Similar Items
-
Discovery of Potential, Dual-Active Histamine H<sub>3</sub> Receptor Ligands with Combined Antioxidant Properties
by: Kamil J. Kuder, et al.
Published: (2021-04-01) -
Influence of betahistine repeated administration on a weight gain and selected metabolic parameters in the model of excessive eating in rats
by: Kamil Mika, et al.
Published: (2021-09-01) -
Effects of GPR18 Ligands on Body Weight and Metabolic Parameters in a Female Rat Model of Excessive Eating
by: Magdalena Kotańska, et al.
Published: (2021-03-01) -
Non-imidazole-based histamine H3 receptor antagonists with anticonvulsant activity in different seizure models in male adult rats
by: Sadek B, et al.
Published: (2016-11-01) -
Low-Histamine Diets: Is the Exclusion of Foods Justified by Their Histamine Content?
by: Sònia Sánchez-Pérez, et al.
Published: (2021-04-01)